Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-Dose Nivolumab Combined With Chemotherapy

NCT06667154 is registered in ClinicalTrials.gov with Aline Fusco Fares, MD as lead sponsor.

NCT NCT06667154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06667154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Analysis of Neoadjuvant Treatment in Lung Cancer Using Low-Dose Nivolumab Combined With Chemotherapy
Lead sponsor
Aline Fusco Fares, MD
Phase
Phase 2
Overall status
Recruiting
Start date
October 10, 2023
Completion date
October 31, 2027
Enrollment
33 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, nonsmall cell, non-small cell lung cancer nsclc